by admin | Apr 11, 2021 | Press Release
MCCARRAN, Nev., Jan. 22, 2019 (GLOBE NEWSWIRE) — Aqua Metals, Inc. (NASDAQ: AQMS), (“Aqua Metals” or the “Company”), which is commercializing its proprietary AquaRefining™ electrochemical lead recycling technology, today announced the closing of its previously...
by admin | Apr 11, 2021 | Press Release
DEER PARK, Ill., Nov. 12, 2018 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced the pricing of its initial public offering of 3,600,000...
by admin | Apr 11, 2021 | Press Release
LOS GATOS, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) — Atomera Incorporated (Nasdaq: ATOM) today announced the closing of its previously announced underwritten public offering of 2,625,000 shares of common stock at a public offering price of $4.75 per share. Atomera has...
by admin | Apr 11, 2021 | Press Release
ALAMEDA, Calif., June 18, 2018 (GLOBE NEWSWIRE) — Aqua Metals, Inc. (Nasdaq:AQMS), (“Aqua Metals” or the “Company”), today announced that it has closed its previously-announced public offering of 10.1 million shares of its common stock at a price to the public of...
by admin | Apr 11, 2021 | Press Release
GOLETA, CA–(March 27, 2018) – Resonant Inc. (NASDAQ: RESN), a designer of filters for radio frequency, or RF, front-ends that specializes in delivering designs for difficult bands and complex requirements, today announced the closing of an underwritten public offering...
by admin | Apr 11, 2021 | Press Release
The Series A financing will support further development of the Company’s pipeline of transformative dry powder drugs for pulmonary diseases and conditions. AUSTIN, Texas, April 3, 2018 /PRNewswire/ — TFF Pharmaceuticals, Inc., an early-stage biopharmaceutical company...